The Latest
-
Hospitals irate after Eli Lilly follows through on 340B ultimatum
The drugmaker stopped paying 340B discounts to hospitals that didn’t comply with its new paperwork requirements late last week. Hospitals are urging HRSA to step in.
-
Sponsored by Amazon Business
Optimizing healthcare procurement: 5 challenges and best practices
Healthcare procurement is a cornerstone of your organization’s operations, but it comes with unique challenges.
-
MultiCare CEO to retire at end of 2026
Florence Chang, a long-time executive of the Washington-based nonprofit, will replace current CEO William Robertson on Jan. 1.
-
HHS, responding to China’s rise, moves to fast-track early drug research
A series of newly planned reforms are designed to entice companies to start early trials in the U.S. rather than overseas.
-
Health services M&A is active in 2026, but uncertainty slows volume: PwC
Buyers are being more selective amid heightened policy and reimbursement pressure in healthcare, according to the analysis. Still, deal value is up compared to the first half of 2025.
-
CMS recalculates Medicare Advantage stars after Clover lawsuit loss, but not a freebie for plans
Regulators are locking in new 2026 stars for plans if they’re higher under the new methodology. But the recalculation basically results in no change to average star ratings unless you’re Clover, analysts say.
-
PCMA sues to exempt PBMs from Illinois drug law
The drug middlemen lobby has had a busy week. It’s the second major lawsuit the PCMA has filed against a state law reforming the PBM industry since Monday.
-
Q&A
Can certification help solve healthcare’s AI governance gap?
Joint Commission leaders explain how the standards group’s new AI certification is designed to work for everyone from major health systems to small rural clinics.
-
Employers plan to shift more health costs to employees
Employers are considering raising premiums and increasing other forms of cost sharing as they grapple with stubbornly rising health costs, according to a new survey from Mercer.
-
The image by Sixflashphoto is licensed under CC BY-SA 4.0
OhioHealth settles antitrust suit with the DOJ
OhioHealth has agreed to void problematic contracts with insurers and not seek such terms moving forward, the Justice Department said. The Ohio nonprofit continues to deny all wrongdoing.
-
CBO asks for more No Surprises research
The No Surprises Act “might not have the effects that CBO anticipated,” the agency wrote in petitioning for more research into the 2020 law’s effect on healthcare prices and other trends. It’s a welcome development for payers.
-
Lifepoint taps new COO
Aaron Lewis, who has served as CFO since 2024, takes on the role as the health system looks to expand its footprint and add new services.
-
Fewer insurers participating in ACA marketplaces amid policy turmoil, KFF finds
The average number of issuers fell from a record high of 9.6 per state in 2025 to just nine this year, according to the health policy research group.
-
Centene offers employee buyouts amid membership losses
Most of Centene’s 61,000 employees will be eligible to apply for voluntary separation. But the program doesn’t amount to a complete overhaul of the company, a spokesperson said.
-
IRhythm discloses data stolen from third-party applications in cyberattack
The cardiac monitoring company said that a threat actor has demanded payment in exchange for not publicly releasing the stolen data.
-
Express Scripts, PCMA sue to block Tennessee law breaking up PBMs and pharmacies
Express Scripts and the PBM lobby are following in CVS Caremark’s footsteps in filing complaints challenging the FAIR Rx Act, which was passed earlier this year despite vehement opposition from PBMs.
-
CMS proposes Medicare coverage expansion for TAVR
The proposed change adds Medicare coverage for beneficiaries with asymptomatic severe aortic valve stenosis who are enrolled in a CMS-approved study.
-
Judge vacates most of controversial 2025 ACA enrollment, eligibility rule
Friday’s decision is a victory for insurance advocates. But, given many of the rule’s provisions were codified in the GOP’s “Big Beautiful Bill,” it’s not a panacea for the ACA.
-
UnitedHealth, FTC reach proposed settlement in insulin case
The tentative deal comes months after CVS reached a proposed settlement in the lawsuit alleging major PBMs are inflating insulin costs. Cigna has already settled with the FTC.
-
Medicare drug price rule may target under-the-skin cancer immunotherapies
For 2029, a federal rule proposes closing a "loophole" that protects medicines transitioning from intravenous administration from price protection.
-
Major Medicare Advantage insurers appear to deny care for profit, federal watchdog finds
MA insurers commonly deny requests for post-acute care — but none more frequently than UnitedHealth, Humana and CVS, the HHS OIG said. Insurers were not happy about the findings.
-
CMS increases oversight of state Medicaid demonstrations
States will have to provide more rigorous financial analyses for their Medicaid demonstrations beginning in 2027, according to new federal guidance.
-
Deep Dive
UHS deal exposes pitfalls of physician group acquisitions
Despite major financial struggles, some providers at a physician group in Washington, D.C. say their new — and much larger — parent is not offering the lifeline they want.
-
Abridge partners with Eli Lilly, Nvidia as AI scribe eyes expansion
The company is working with Nvidia to build a foundation model for clinical conversations, and it scored a strategic investment from drugmaker Eli Lilly, Abridge announced during a sweeping keynote.
-
CMS creates office dedicated to health technology
The Office of Health Technology and Products is the latest technology development from the CMS as it doubles down on digital tools.
-
Health plans say AI is pushing healthcare costs higher
Nearly 70% of surveyed health plans said providers’ use of AI documentation and coding tools was a top three trend inflating commercial healthcare costs next year, according to a new report from PwC.